MicroRNA Screening Identifies Circulating MicroRNAs As Potential Biomarkers for Osteosarcoma

Overview

Journal Oncol Lett

Specialty Oncology

Date 2015 Dec 2

PMID 26622728

Citations 23

Authors

Hui Li

Kun Zhang

Li-Hong Liu

Yurong Ouyang

Hong-Bin Guo

Hanchong Zhang

Jie Bu

Tao Xiao

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are a family of small non-protein coding RNAs, which regulate the expression of a wide variety of genes at the post-transcriptional level to control numerous biological and pathological processes. Various circulating miRNAs have been identified as potential diagnostic and prognostic biomarkers in multiple types of cancer and disease. The aim of the present study was to identify potential miRNA biomarkers for the early diagnosis and relapse prediction of osteosarcoma (OS). miRNA profiling was performed on serum from patients with osteosarcoma and healthy controls. All putative miRNAs were verified by reverse transcription-quantitative polymerase chain reaction analysis of 20 pre-therapeutic OS patients and 20 healthy individuals. The expression of miR-106a-5p, miR16-5p, miR-20a-5p, miR-425-5p, miR451a, miR-25-3p and miR139-5p was demonstrated to be downregulated in the serum of OS patients when compared with that of the healthy controls. Receiver-operating characteristic curve analyses indicated that these 7 miRNAs may be used as diagnostic biomarkers with the ability to discriminate between the healthy cohort and patients with OS. These results provide novel insights into the use of miRNAs in early blood screening for OS.

Citing Articles

A comprehensive overview of liquid biopsy applications in pediatric solid tumors.

Janssen F, Lak N, Janda C, Kester L, Meister M, Merks J NPJ Precis Oncol. 2024; 8(1):172.

PMID: 39097671 PMC: 11297996. DOI: 10.1038/s41698-024-00657-z.

Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.

Fujii T, Nishio E, Tsukamoto T, Kukimoto I, Iwata A Cancer Sci. 2024; 115(8):2795-2807.

PMID: 38749770 PMC: 11309926. DOI: 10.1111/cas.16214.

Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2.

Ye J, He H, Chen S, Ren Y, Guo W, Jin Z Int J Clin Oncol. 2022; 27(12):1891-1903.

PMID: 36269529 DOI: 10.1007/s10147-022-02245-2.

Regulatory mechanism of miR-20a-5p expression in Cancer.

Huang W, Wu X, Xiang S, Qiao M, Cen X, Pan X Cell Death Discov. 2022; 8(1):262.

PMID: 35577802 PMC: 9110721. DOI: 10.1038/s41420-022-01005-5.

Circulating MicroRNAs as Novel Potential Diagnostic Biomarkers for Osteosarcoma: A Systematic Review.

Gally T, Aleluia M, Borges G, Kaneto C Biomolecules. 2021; 11(10).

PMID: 34680065 PMC: 8533382. DOI: 10.3390/biom11101432.

References

Liu N, Jiang N, Guo R, Jiang W, He Q, Xu Y . MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol Cancer. 2013; 12(1):123. PMC: 3853142. DOI: 10.1186/1476-4598-12-123. View

Xu J, Liu P, Si M, Ding X . MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1. Tumour Biol. 2013; 34(6):3871-7. DOI: 10.1007/s13277-013-0974-x. View

Li R, Chen L, Zhang H, Du W, Feng Y, Wang H . MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. CNS Neurosci Ther. 2013; 19(7):477-83. PMC: 6493424. DOI: 10.1111/cns.12089. View

Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E . Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep. 2012; 29(1):169-76. DOI: 10.3892/or.2012.2105. View

Chen L, Wang Q, Wang G, Wang H, Huang Y, Liu X . miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS Lett. 2013; 587(9):1366-72. DOI: 10.1016/j.febslet.2013.03.007. View

Jones K, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo G . miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 2012; 72(7):1865-77. PMC: 3328547. DOI: 10.1158/0008-5472.CAN-11-2663. View

Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F . MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A. 2011; 108(9):3713-8. PMC: 3048155. DOI: 10.1073/pnas.1100048108. View

Xu X, Chen Z, Zhao X, Wang J, Ding D, Wang Z . MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Commun. 2012; 421(4):640-5. DOI: 10.1016/j.bbrc.2012.03.048. View

Zhou X, Wei M, Wang W . MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun. 2013; 437(4):653-8. DOI: 10.1016/j.bbrc.2013.07.033. View

10.

Sand M, Skrygan M, Sand D, Georgas D, Hahn S, Gambichler T . Expression of microRNAs in basal cell carcinoma. Br J Dermatol. 2012; 167(4):847-55. DOI: 10.1111/j.1365-2133.2012.11022.x. View

11.

Kobayashi E, Hornicek F, Duan Z . MicroRNA Involvement in Osteosarcoma. Sarcoma. 2012; 2012:359739. PMC: 3329862. DOI: 10.1155/2012/359739. View

12.

Shen L, Chen X, Zhang Y . MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. Tumour Biol. 2013; 35(3):2069-74. DOI: 10.1007/s13277-013-1274-1. View

13.

Bian H, Pan X, Yang J, Wang Z, De W . Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res. 2011; 30:20. PMC: 3051912. DOI: 10.1186/1756-9966-30-20. View

14.

Ng E, Li R, Shin V, Jin H, Leung C, Ma E . Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One. 2013; 8(1):e53141. PMC: 3536802. DOI: 10.1371/journal.pone.0053141. View

15.

Wang Y, Zhao W, Fu Q . miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 2013; 384(1-2):105-11. DOI: 10.1007/s11010-013-1786-4. View

16.

Diaz R, Silva J, Garcia J, Lorenzo Y, Garcia V, Pena C . Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer. 2008; 47(9):794-802. DOI: 10.1002/gcc.20580. View

17.

Menendez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menendez J . Prognostic implications of serum microRNA-21 in colorectal cancer. J Surg Oncol. 2013; 108(6):369-73. DOI: 10.1002/jso.23415. View

18.

Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H . Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer. 2011; 105(11):1733-40. PMC: 3242609. DOI: 10.1038/bjc.2011.453. View

19.

Sita-Lumsden A, Dart D, Waxman J, Bevan C . Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer. 2013; 108(10):1925-30. PMC: 3670496. DOI: 10.1038/bjc.2013.192. View

20.

Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T . Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci. 2009; 101(1):241-9. PMC: 11159282. DOI: 10.1111/j.1349-7006.2009.01385.x. View